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ABSTRACT 
Kevin G. Lim: A retrospective clinical study evaluating full-arch monolithic zirconia implant 
supported fixed dental prosthesis 
(Under the direction of Ingeborg De Kok) 
 
 The metal-acrylic implant supported fixed dental prosthesis (MAISFDP) is the most 
commonly reported fixed implant prosthesis used to treat edentulism. Although favorable long-
term implant and prosthetic survival rates have been demonstrated, complications involving the 
material such as veneer fracture can occur at a high rate. The monolithic zirconia implant 
supported fixed dental prosthesis (MZISFDP) is proposed to offer similar favorable outcomes as 
MAISFDP with fewer complications. This retrospective study shows that over a mean follow-up 
period of 41 months, MZISFDPs demonstrate high implant and prosthetic survival rates (100%) 
with highly favorable patient reported outcomes. Technical complications such as veneering 
fracture are lower (14%) but a unique set of complications such as debonded MZISFDP titanium 
abutments can occur. The biological complications reported in the study are similar to those 
reported in other MAISFDP studies. This study shows that MZISFDPs are a viable treatment 
option for edentulism. 
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INTRODUCTION 
1.   Epidemiology 
Prevalence of complete tooth loss (edentulism) declined dramatically in the United States 
(U.S.)  over five decades1 from a peak of 18.9% in 1957-58 to 4.9% in 2009-2012. By 2050, 
edentulism is projected to reach 2.6 %. 1 Despite the passing of this cohort, the combined effects 
of population growth, an aging population and continuing dental disease, will ensure continued 
need for complete denture treatment.2 Based on national epidemiological survey data, the adult 
population in need of one or two complete dentures will continue to increase to 37.9 million 
adults in 2020 as compared to 35.4 million adults in 2000.3  
According to the Centers for Disease Control and Prevention (CDC), 18.6% of U.S. adults 
aged 65 years or older were edentulous in 2011-2012.4 Edentulism was twice as prevalent in adults 
over the age of 75 (26.8%) compared to adults aged 65-74 (13%). 4 These surveys indicate that a 
large majority of the elderly population in the United States are still in need of dental treatment for 
edentulism. Other than increasing age, other factors such as race5, socioeconomic status6, lower 
educational attainment, decreased access to dental care, and decreased insurance coverage also 
contribute to both tooth loss5 and edentulism. 7 8 
Based on World Health Organization (WHO) criteria, completely edentulous patients are 
considered to be physically impaired, disabled and handicapped.9 10 11 For the edentulous patient, 
their handicap arises from the inability to eat and speak adequately or from their avoidance to eat 
and speak in public.12 Furthermore, complete edentulism is associated with poor nutrition, high 
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levels of obesity and multiple systemic disorders such as cardiovascular disease and COPD-related 
events.13 14 Edentulism also has a negative effect on social interaction and day-to-day activities.15 
The compromised oral function has been linked to decreased self-esteem and decline in 
psychosocial well-being.16 The edentulous patients’ reluctance to participate in social activities 
due to their embarrassment to speak, smile, or eat in public because of problems with their teeth 
and dentures can lead to social isolation. 17  
2.   Treatment of Edentulous Patients 
2.1. Complete Denture Therapy 
Complete denture therapy has long been the most common way to treat edentulism.18 In 
the absence of a better alternative, complete denture therapy was a satisfactory treatment option. 
19 Berge attributes the construction of a good set of complete dentures to the technical, 
biological, and psychological interactions between the patient and dentist. 20 Yet despite the 
fabrication of new and well-made conventional dentures, 10-15% of patients remain dissatisfied 
with the results. 21 22  
Complete denture therapy introduces its own set of related complications23. Some 
common complications include pain, discomfort, poor denture stability, and discomfort while 
eating. 24 These functional complications may be attributed to anatomical concerns such as 
continual ridge resorption25 and decreased salivary flow26 which compromise stability, support, 
and retention of the complete denture. Other physiologic factors such as diminished oral sensory 
function27 and decreased motor control of the tongue28 can also affect complete denture 
performance leading to diminished chewing efficiency.29  
Aside from functional problems, complete denture therapy outcomes may not meet the 
psychological or social needs of the individual.30 Some of these may not be due to the technical 
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fabrication or the biological status of the patient but their psychological intolerance. Cooper 
identifies these patients as the maladaptive patients, who fail to adapt to their dentures regardless 
of the technique or quality of the denture. 23 In an investigation on the influence of patient 
personality on satisfaction with the use of complete dentures, Fenlon et al31 found that patients 
with neurotic personalities were significantly less satisfied with their complete dentures. These 
maladaptive denture patients must be responded to “not solely through technical aspects of 
denture construction but also through patient personality and socioeconomic features”.23 
2.2. Endosseous Dental Implant Therapy 
In 1965, Brånemark and colleagues introduced endosseous dental implants as a fixed 
treatment option for the edentulous mandible and later extended their use in treatment of the 
edentulous maxilla. Advantages of employing dental implants in prosthodontic treatment include 
increased stability and comfort of the prosthesis.23 Twenty-year follow-up of implant and fixed 
prosthesis show a cumulative survival rate of 98.9% and 95.6%, in the mandible32 and15-year 
implant and fixed prosthesis cumulative survival rates of 90.9% and 90.6% in the maxilla33. 
Some biological advantages of implant therapy include the preservation of bone levels34, the 
induction of bone in the posterior mandible,35 increased stability and retention of the prosthesis36, 
and increased masticatory function.37 In the maladaptive psychosocially disabled denture 
wearing patient, dental implants offered improved comfort, function, speech self-image, and 
overall dental health.38 Often times these patients present requesting dental implant therapy as 
they report more psychosocial and functional problems and are harder to satisfy than patients 
requesting conventional dentures.39 For all edentulous patients, especially the maladaptive 
denture wearing patient, dental implant therapy may offer a significant improvement in oral 
health related quality of life (OHRQoL) when compared to conventional dentures.40 
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2.3. Implant-Supported Prosthetic Options 
 Proper examination and diagnosis are paramount in the treatment planning of implant-
supported or retained prosthesis. Proper assessment of esthetics, occlusal vertical dimension, 
medical history, and radiographic data are just some of factors that determine the efficacy of the 
implant prosthesis.41 42 43 With dental implant therapy, especially in the esthetic zone, careful 
consideration of the transition line, defined as the prosthetic tissue junction, must be made to 
ensure that it is hidden with fixed implant restorations.44 Differing amounts of space must also be 
available depending on the type of implant prosthesis. When measured from the soft tissue to the 
opposing dentition (restorative space) they can range from 8-9 mm for a locator retained implant 
supported overdenture (ISOD)45 to a minimum of 10-12 mm46 for a fixed metal-acrylic implant 
supported fixed dental prosthesis (ISFDP), commonly known as a metal-acrylic hybrid 
prosthesis.  Failure to fulfill these space requirements can lead to early implant prosthesis failure 
or patient refusal. There are two main types of dental implant prosthesis for the edentulous 
patient, a removable option and a fixed option.  
2.4. Removable Dental Implant Prosthesis 
 Some indications for a removable implant prosthesis include the need for facial 
scaffolding to provide lip or cheek support, 47 48 improved oral hygiene access 49 and initial cost 
savings.42 In addition, when compared to fixed dental implant prosthesis, there may be more 
freedom for implant placement positioning50 51 as well as an increased ease to reconcile inter-
arch discrepancies.51 In the maxilla, this form of prosthesis is often indicated in patients with 
intolerance for palatal coverage and treatment for refractory gagging.52 The removable implant 
prosthesis is often referred to as an overdenture prosthesis and can either be completely implant-
supported or implant- and tissue-supported.53  
  
     
5  
2.4.1. Implant-Supported Overdentures (ISOD) 
 The implant-supported overdenture is often indicated in patients with advanced ridge 
resorption, high muscle attachments, sensitive mucosa, or knife-edge ridges54 that become easily 
irritated by the pressure exerted by a denture.55 Typically, 4-6 dental implants are placed to 
maximize anterior-posterior spread, when anatomically possible, rigidly connected by a bar 
suprastucture.56 The implant overdenture prosthesis is then supported entirely by the 
suprastructure making it implant-supported rather than implant- and tissue-supported. Various 
attachments such as hader clips and locator abutments (Zest Anchors LLC, Carlsbad, CA) help 
retain the overdenture to the bar superstructure. Furthermore, depending on the number of 
implants, quality of bone, and length of cantilever the bar suprastructure allows for increased 
loads during mastication.57 Careful bar design may also allow for less maintenance and better 
oral hygiene.58 
 The fixed removable prosthesis was first reported in 198259 as an implant prosthesis 
entirely supported by the implants. A bar suprastructure connecting to the implants is either 
precisely cast or milled with a specific taper which provides frictional retention for a metal 
suprastructure that is then incorporated into the prosthesis.53 Additional retention is provided by 
frictional pins. This form of treatment provides added rigidity, similar to that provided by a fixed 
implant prosthesis, but with better access for hygiene. Disadvantages include high laboratory 
fees, technique laboratory fabrication, and necessary patient dexterity to undo the frictional 
pins.60 Some examples of the fixed removable implant prosthesis include the Marius implant 
bridge61 and the more recent implant-supported overdentures utilizing Atlantis Conus abutments 
(Denstply, Molndal, Sweden).  
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2.4.2. Implant-and Tissue-Supported Overdentures 
 In addition to implants, the implant- and tissue-supported overdenture relies on the 
mucosa for support. Fewer implants are usually required. Four evenly distributed implants in the 
maxilla allow for a palate-less design of the overdenture. Two implants in the anterior segment 
of the mandible are the minimum implants needed to support an overdenture in the mandible and 
is regarded as the standard of care for restoring fully edentulous mandibles.62 Similar to implant-
supported overdentures, a bar suprastructure can be beneficial when divergently placed implants 
exist but require additional restorative space.  Solitary anchorage systems such as locator 
attachments (Zest Anchors LLC, Carlsbad, CA), ERA attachments (Sterngold, Attleboro, MA), 
and ball abutments require more parallel implant placement but can be a better option when 
patients have limited finances, poor oral hygiene, and limited keratinized tissue.63 In addition, the 
implant- and tissue-supported overdenture requires the least amount of restorative space45 and is 
better suited in the presence of excessive cantilevers.64  It is also associated with reduced surgical 
risks, especially in medically compromised individuals, as the surgical procedures are shorter in 
duration and less invasive.55 One disadvantage, common to any prosthesis employing acrylic 
denture teeth, is the increased susceptibility to wear. The use of different materials such as metal 
occlusals65 and zirconia66 teeth have been used in complete dentures to resist wear.  
2.5. Implant Supported Fixed Dental Prosthesis (ISFDP) 
 Indications for fixed dental implant prosthesis are the presence of marked residual ridge 
resorption67 68 35 (which are not favorable for the construction of mucosa supported 
overdentures), tapered arch forms69, and temporomandibular joint disorders70. Additionally, 
ISFDPs may also be beneficial in preventing Kelly combination syndrome71 and have potential 
for reduced maintenance.72 For patients wishing to masticate hard foods43 and the psychological 
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assurance of prosthesis retention security53 the fixed dental implant prosthesis is advantageous. 
In general, these fixed implant prostheses require more implants, additional pre-prosthetic 
surgical procedures, highly skilled laboratory support, and higher overall treatment costs. 
2.5.1. Ceramometal Implant Supported Fixed Dental Prosthesis  
 Ceramometal ISFDPs are indicated when there is limited alveolar resorption and only the 
restoration of the tooth defect, ideally without prosthetic gingiva, is needed.73 Of all the ISFDP 
prosthetic options, the ceramometal ISFDP requires least amount of restorative space; only 
7mm.45 They can also be highly esthetic, achieve excellent phonetics, and are quite functional.46  
The ceramometal material requires less bulk while maintaining high strength and allows for 
hygienic restoration that may require reduced maintenance.53  
 The main disadvantages associated with ceramometal ISFDPs is the requirement for high 
technique sensitivity in ideal placement of 6-8 implants and a highly skilled laboratory to 
fabricate the prosthesis.53 Together these can greatly increase cost.  Ceramic fractures are the 
most commonly reported complications with these implant prostheses. In fact, a threefold 
increase in ceramic veneer fractures are noted in ceramometal ISFDPs when compared to their 
tooth supported counterparts.74 Additionally, Kinsel and Lin reported a sevenfold increase in 
ceramic fractures when ceramometal ISFDPs opposed an implant supported prosthesis or in the 
presence of bruxism.75 Their 10-year prosthesis survival rate was 96.4% in the maxilla76 and 
100% in the mandible.77 Despite these positive long term results, that this form of ISFDP is the 
least reported and long term implant and prosthetic studies are limited.78  
2.5.2. Metal-Acrylic Implant Supported Fixed Dental Prosthesis (MAISFDP) 
 The metal-acrylic ISFDP (MAISFDP), also known as the “fixed detachable prosthesis” or 
the “metal-acrylic hybrid” was the first implant supported prosthesis introduced by PI Brånemark 
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over 50 years ago. Unlike the ceramometal ISFDPs, MAISFDPs are the most common ISFDP 
found in dental literature and are also the most commonly prescribed ISFDP option.79 Compared 
to ISODs, the MAISFDP offers increased comfort, stability, and improved chewing ability.80 In a 
direct crossover study comparing ISOD supported by 4 implants versus MAISFDPs within the 
same patient, the MAISFDPs demonstrated better stability and chewing function while the ISOD 
demonstrated better esthetics and easier cleansing ability. 81 Watson et al. also showed that the 
long-term costs associated with ISODs may surpass the initial savings of the upfront fees 
required for MAISFDPs. A major disadvantages of this prosthesis is the requirement of at least 
12mm of restorative space, and preferably 15mm.45  When insufficient restorative space is 
available further surgical intervention is indicated for the removal of hard and soft tissue. 
 A systematic investigation of the biological and technical complications associated with 
MAISFPs by Papaspyridakos et al. found that the percentage of these prosthesis estimated to be 
free of complications after 5 and 10 years were 29.3% (26.6-32.2%) and 8.6% (7.1-10.3%) 
respectively.78  When the implant-related complications were examined, the most common 
biologic complications was bone loss (> 2mm), with 5- and 10-year cumulative estimated 
complication rates (95% CI) of 20.1% (17.7-22.6%) and 40.3% (36.9-43.7%), respectively and 
peri-implant mucositis 5- and 10-year cumulative estimated complication rate (95% CI) of 
10.5% (7.6-13.4%) and 21.1% (16.9-25.2%) respectively. Technical complications related to the 
implants were screw fractures, with 5- and 10-year cumulative estimated complication rates 
(95% CI) of 10.4% (8.8-12.0%) and 20.8% (18.5-23.1%) respectively, and screw loosening, with 
5- and 10-year cumulative estimated complication rates (95% CI) of 9.3% (7.9-10.6%) and 
18.5% (16.6-20.4%) respectively. A summary of the prosthesis-related complications revealed 
biologic complications that included hypertrophy or hyperplasia of tissue, with 5- and 10-year 
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cumulative estimated complication rates (95% CI) of 13% (10.6-15.4%) and 26.0% (22.6-29.3%) 
respectively, and inflammation under the prosthesis, with 5- and 10-year cumulative estimated 
complication rates (95% CI) of 5.4% (4.1-7.1%) and 11.3% (9.2-13.4%) respectively. Technical 
complications included veneering material chipping/fracture, with 5- and 10-year cumulative 
estimated complication rates (95% CI) of 33.3% (31.1-35.5%) and 66.6% (63.5-69.7%) 
respectively, total replacement of acrylic resin teeth, with 5- and 10-year cumulative estimated 
complication rates (95% CI) of 16.2% (14.1-18.3%) and 32.4% (29.4-35.4%) respectively, and 
wear of acrylic resin teeth, with 5- and 10-year cumulative estimated complication rates (95% 
CI) of 10.0% (7.7-12.3%) and 20.0% (16.8-23.2%) respectively. A separate systematic review by 
Bozini et al.82 revealed similar results and could not find any studies that directly compared the 
incidence of prosthodontic complications between ceramometal and MAISFDPs. In fact, no 
ceramometal ISFDP related study fulfilled their criteria for inclusion.  
2.6. Patient centered outcomes 
2.6.1. Oral Health Impact Profile (OHIP) 
In dentistry, as well as healthcare overall, there has been a shift to incorporate the 
patient’s experience and physical functioning when defining appropriate treatment goals and 
evaluating outcomes.83  Along the lines of patient-centered outcomes is the direct impact that 
oral health has on dimensions of physical, psychological and social outcomes. The Oral Health 
Impact Profile (OHIP) is a questionnaire designed to assess the perception of the adverse impact 
of oral disorders on well-being.84 The OHIP, developed by Slade in 1994, consists of seven 
theoretical dimensions of impact. These dimensions were developed for overall health by the 
World Health Organization and subsequently modified for oral health by Locker. 85  These seven 
dimensions are: functional limitation, physical pain, psychological discomfort, physical 
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disability, psychological disability, social disability, and handicap. In its full scale, the OHIP-49, 
consists of 49 questions, 7 questions per dimensions. Responses are made on a 5-point ordinal 
that records the frequency of adverse impact as: “very often (scored 4)”, “fairly often (3)”, 
“occasionally (2)”, “hardly ever (1)”, and “never (0)”. In computing the OHIP severity score, 
these responses are summed. The higher the severity score the greater the adverse impact of oral 
health. More recently these adverse impacts have been described as a measure of oral health 
related quality of life (OHRQoL). The OHIP-49 is a reliable and valid instrument for the detailed 
measurement of the social impact of oral disorders.86 Slade latter derived a subset of 14 OHIP 
items that consists of 2 questions from each of the 7 dimensions. This shortened scale known as 
the OHIP-14 has been validated and has a high reliability.84  
2.6.2. OHIP and Implant Prosthesis 
  In a retrospective study, Brennan et al.87 used the OHIP-14 to compare patient outcomes 
between full-arch ISFDPs and ISODs. Although the ISOD group showed worse OHRQoL scores 
across each of the 7 OHIP-14 dimensions, as evidence by higher OHIP scores, only two 
dimensions, psychologic discomfort and psychologic disability, showed statistically significant 
differences when compared to the implant fixed complete denture group. However, when only 
the maxilla was examined, the maxillary ISODs consistently reported higher OHIP-14 scores, 
indicating lower OHRQoL, but only the domain of handicap was significantly different when 
compared to the scores of the full-arch ISFDP. A separate patient satisfaction survey was also 
administered that showed overall satisfaction with the full-arch ISFDP was significantly higher 
than the ISOD. The full-arch ISFDP had significantly better results in esthetics and chewing 
capacity. Additionally, in the maxilla, patients with the ISOD were significantly less satisfied 
with esthetics, overall duration of treatment, and willingness to undergo the same procedure 
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over. 
  In a prospective study by Oh et al.88, patient satisfaction and OHRQoL among fully 
edentulous patients treated with either full-arch ISFDP, ISOD, or complete dentures were 
evaluated prior to and  post prosthetic treatment. A comparison of OHIP-14 scores before and 
after prosthetic treatment demonstrated improved quality of life (QoL) in all three groups. The 
median difference in OHIP-14 scores for all three groups showed no statistically significant 
difference between the ISFDP and ISOD groups. But when compared to the complete denture 
group, the ISFDP group showed greater improvements in OHRQoL and statistically significant 
improvements in the following OHIP-14 dimensions: functional limitation, physical pain, 
psychological discomfort, and psychological disability. The ISOD, when compared to the 
complete denture, had statistically greater improvements in the dimension of functional 
limitation.  
2.6.3. Quality of Life related of Function, Aesthetics, Socialization, Thoughts about health-
behavioral habits’ (QoLFAST-10) 
The Quality of Life related to Function, Aesthetics, Socialization, Thoughts about health-
behavioral habits’ (QoLFAST-10)89 is a new customized index that consists of 10 items that 
represent the different aspects through which OHRQoL can be evaluated. The ten items are: 1) 
social repercussion of oral pain; 2) social repercussion of eating well; 3) speaking well; 4) 
satisfaction with the size, shape, and color of the prosthetic teeth; 5) self-confidence when smiling; 
6) development of daily activities; 7) feeling socially comfortable, 8) importance of dental 
revisions; 9) importance of daily habits of oral hygiene, and 10) oral hygiene difficulties and are 
evaluated based on an ordinal scale that correspond to the patient’s response to each of the 
questions. The five potential responses with their respective scores are: “strongly disagree (-2)”, 
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“disagree (-1)”, “indecisive, indifferent, or neutral (0)”, “agree (+1)”, and “strongly agree (+2)”. 
The higher the score indicates a more positive outcome towards the patient’s OHRQoL. Castillo-
Oyagüe R et al.89 validated the QoLFAST-10 against the Oral Health Impact Profile-20 (OHIP-
20) by comparing the OHRQoL in edentulous patients who were treated with either complete 
dentures, ISOD, or MAISFDP. The OHIP-20 results showed that the MAISFDP group did 
significantly better in improving overall OHRQoL (lower overall OHIP-20 severity scores) than 
the ISOD group but did not significantly improve OHRQoL (similar OHIP 20 scores). The 
MAISFDPs had significantly less physical pain than the ISOD but similar physical pain to the 
complete denture group. The QoLFAST-10 results showed similar results to the OHIP-20. Based 
on the overall QoLFAST-10 scores, the MAISFDP showed statistically higher scores, and thus 
greater improvement in OHRQoL, than the ISOD group but no statistical difference when 
compared with the complete denture group. The differences were significant in the “functional” 
and “thoughts about health-behavioral habits” categories only between the MAISFDP and the 
ISOD but not between the MAISFDP and the complete denture groups. Both the OHIP and 
QoLFAST-10 provide patient-centered information that shows potential benefits in decision 
making between different prosthetic treatment options as they play a key role in the patient 
satisfaction with the prosthesis. 
 OHRQoL studies have shown that edentulous patients prefer the ISFDP due to the 
increased comfort and stability. Additionally, there may also be a psychological aspect of a fixed 
restoration that helps with psychological discomfort and disability. The MAISFDP is the most 
commonly used ISFDP and despite its high patient acceptance, there is a unique set of 
complications that must be addressed. Technical complications such as veneer fracture and/or 
chipping is estimated to occur anywhere between 30.6-33.3% at 5 years and 51.9-66.6% at 10 
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years82 78respectively. Other technical complications related to the material such as the 
replacement of acrylic resin teeth and wear of acrylic resin teeth occur at 16.2% and 10%, 
respectively after 5 years, and 32.4% and 20%, respectively after 10 years. 78 Due to the high 
complication rates related to material, an alternative material such as zirconia may be indicated 
for ISFDP fabrication.  
3. Zirconia 
3.1. Material Properties and Use 
 Zirconia may offer advantages when fabricating full-arch ISFDPs. In the 1960s, zirconia 
was proposed as a new hip material to replace titanium or alumina prostheses.90 In the 1980s, 
Christel and colleagues used zirconia implants in orthopedic surgery.91 Then in the 1990s, 
zirconia was introduced in dentistry.92 
 Zirconia has many desirable properties for a dental material including low thermal 
conductivity,93 low corrosion potential, 93 good radiopactiy,93 high biocompatibility94 and low 
bacterial surface adhesion.95 Zirconia is a polymorphic material that in its pure form exists in 
three phase that are temperature dependent: 1) monoclinic phase (room temperature to 1170 °C); 
2) tetragonal phase (1170-2370°C); and 3) cubic phase (2370°C - melting point).92 Different 
stabilizing oxides such as magnesia, ceria, and yttria allow the tetragonal phase to be retained at 
room temperature. It is in its tetragonal phase that we use zirconia in dentistry. In the tetragonal 
phase a phenomenon known as transformation toughening can occur which can be beneficial.  
Transformation toughening occurs as a response to mechanical stimuli when the partially 
stabilized crystalline zirconia changes from the tetragonal phase to the more stable monoclinic 
(Figure 1) phase.96 A local volume increase of approximately 4% occurs and prevents further 
crack propagation by compression of the crack tip (Figure 1). Other mechanical properties such 
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as high flexural strength (900-1200 MPa) and high fracture toughness (9-10 MPa • m1/2 ) are also 
beneficial properties97 . 
Figure 1: Transformation toughening in zirconia
 
 
When a force strong enough causes a crack to propagate, the tetragonal crystals transform into 
the monoclinic form increasing in volume. This volume increase prevents the crack from further 
propagating into the material.  
 
 There are three zirconia-containing ceramic systems available in dentistry: 1) Yttrium 
cation-doped tetragonal zirconia polycrystals (3Y-TZP); 2) Magnesium cation-doped partially 
stabilized zirconia (Mg-PSZ, Denzir M, Dentronic AB, Sweden); 3) Zirconia-toughened alumina 
(ZTA, In-Ceram, Vita Zahnfabrik). 98 Porosity and large grain size has limited the success of 
Mg-PSZ.99  3Y-TZP is the most commonly used in dentistry. They have been used to 
manufacture root canal posts100, frameworks for single posterior tooth or implant-supported fixed 
dental prosthesis(FDP), frameworks for multi-unit tooth or implant-supported FDPs101, custom-
made bars used to support fixed and removable dental prosthesis102, implant abutments103 and 
dental implants104.  
3.2. Manufacturing Process 
 For dental purposes, the manufacturing of zirconia involves the use of computer-aided 
design/computer-aided manufacturing technology (CAD/CAM) for the design of the prosthesis 
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and subtractive rapid protoyping technology for the fabrication.105 Subtractive rapid protoyping 
refers to the machining or milling process that removes material from solid blocks to fabricate 
customized three dimensional objects that are usually designed by various computer-design 
software.106 Due to the hardness and poor machinability of fully sintered zirconia, most available 
CAD/CAM systems shape blocks of partially sintered zirconia. These partially sintered blocks 
are commonly referred to as their “green state”. After they are milled, they are 25% larger and 
weaker than their final state. The sintering process shrinks the prosthesis to the final dimensions 
and to their full strength.107 The reproducible and consistent CAM process108, along with the 
decrease in labor intensive processing109, and decease in the cost of materials110 has resulted in 
the increased use and cost-effectiveness of CAD/CAM fabricated restorations.  
3.3. Disadvantage: Low Temperature Degradation 
 One of the major disadvantages unique to zirconia is the process known as low 
temperature degradation (LTD). Kobayashi and colleagues first described LTD in 1981.111 It 
refers to the accelerated aging112 113 that occurs when zirconia is exposed to moisture, which 
include bodily fluids and water vapors. 114 115 Sato and Shimada hypothesized that water subjects 
zirconia to accelerated crack growth in pre-existing flaws and promotes phase transformation 
from the more stable tetragonal phase to the monoclinic phase.116 The increased presence of the 
monoclinic phase leads not only to the reduction in strength, toughness, and density but also 
micro and macro cracking of the material.117 Further water contamination exacerbates this 
process of surface degradation. 117 Other factors such as grain size,118 amount of stabilizer,119 and 
the presence of residual stress120 121 are detrimental to the stability of the tetragonal phase of 
zirconia and can promote LTD. Currently, there is no clear correlation between LTD and failure 
predictability of zirconia when used as a dental bioceramic.  
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4. Zirconia-Based Dental Prosthesis 
Zirconia was initially used as a framework or substructure material, substituting metal 
frameworks used in ceramometal dental prosthesis. Feldspathic porcelain was then veneered onto 
the zirconia framework. A systematic review by Le and colleagues122 compared the clinical 
success of tooth- and implant- supported zirconia based dental prosthesis. A total of 27 studies 
were reviewed, 23 of which were tooth-supported zirconia based FDPs and 4 which were zirconia-
based ISFDPs (ZBISFDPs). Three out of 4 of the ZBISFDP studies involved full-arch ZBISFDPs. 
The 5-year cumulative survival rate for the ZBISFDPs was 100% while it was 93.5% for tooth-
supported zirconia-based FDPs. A common complication related to the zirconia-based material in 
both implant- and tooth-supported FDPs was the fracturing of the veneering porcelain. Veneer 
fracture complications occurred in 88% of ISFDPs while veneer fracture failures occurred in 53% 
of tooth-supported FDPs. 5-year complication rates of ZBISFDPs (30.5%) were also higher than 
tooth-supported FDPs (27.6%). Furthermore, these complications occurred within the first two 
years. 
4.1. Work Flow and Fabrication 
 The design of the framework can be made by making a resin full contour pattern of the 
final prosthesis and applying a cutback to provide a resin framework pattern.105 The resin pattern 
can then be scanned to generate a three-dimensional CAD file that can be transferred to a CAM 
milling center where the framework can be milled from a pre-sintered zirconia block and 
sintered. Conversely the full contour cutback framework can also be designed on a computer 
design software for CAM milling. The framework is then verified in the patient and feldspathic 
porcelain is layered to establish the final contours of the prosthesis.  
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4.2. Clinical Studies on Full-Arch Zirconia-Based Implant Supported Fixed Dental 
Prosthesis (ZBISFDPs) 
 Papaspyridakos and Lal123 provided clinical results of 14 edentulous patients who were 
restored with 16 full-arch ZBISFDPs, supported on 6-8 implants in the maxilla and 5-8 implants 
in the mandible, after 2-4 years in function. They examined biological and technical 
complications as well as patient satisfaction that focused on esthetics and occlusion. The survival 
rates for both the implants and prostheses was 100%. The most common technical complications 
encountered was veneer chipping/fracturing that occurred in 5/16 (31.25%) of the prosthesis. In 
3 out of the 5 ZBISFDPs, the veneer chipping was minor and was either polished or had 
composite resin added intraorally without compromising function or esthetics. In one patient 
with both maxillary and mandibular ZBISFDPs major cohesive fractures occurred in the 
veneering porcelain that required laboratory repair. No screw loosening or zirconia framework 
fractures occurred and bone loss after 2 years were minimal (0.1mm). The patients were highly 
satisfied with both function and esthetics. Although porcelain fracture/chipping was the main 
complication, the short-term clinical results show that ZBISFDPs may be a viable prosthetic 
option for the fully edentulous patient. Some risk factors for ceramic chipping identified were the 
presence of parafunctional activity, opposing full-arch ISFDPs, and the absence of occlusal 
guard use. 
5. Monolithic Zirconia Implant Supported Fixed Dental Prosthesis (MZISFDP) 
 Porcelain fracture in ZBISFDPs poses a major limitation. In fact, these porcelain-fused-
to-zirconia (PFZ) restorations show a 7% higher rate of chipping/fracture when compared to 
traditional porcelain-fused-to-metal (PFM) restoration.124 Thalji and Cooper proposed the 
omission of the veneering porcelain, especially in the non-esthetic areas, in full-arch zirconia 
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ISFDPs to reduce or eliminate the risk of porcelain chipping or fracture.125 Thus the design and 
fabrication of zirconia full-arch ISFDPs employ use of zirconia in a monolithic or minimally 
veneered form to eliminate or greatly reduce the need for veneering porcelain. 126  
Additional advantages for fabricating monolithic zirconia ISFDPs (MZIFDPs) include 
the decreased incidence of framework fracture125 127 128 by allowing for larger connectors,129 and 
thus potential catastrophic failures, as well as decreased wear130 to opposing natural dentition 
when compared to feldspathic porcelain.  
5.1. Work Flow and Fabrication 
 The workflow for MZISFDP design and fabrication is similar to the previously discussed 
workflow for ZBISFDPs except it takes better advantage of the CAD/CAM workflow allowing 
for higher predictability, efficiency and consistency. From a verified stone/plaster implant model 
a full contour design of the MZISFDP can be designed entirely on a computer using dental 
design software. The design is then milled out of fully-cured poly-methyl-methacrylate (PMMA) 
and fitted in the patient. The patient can function in the prosthesis for a period of time and 
changes can be made in the PMMA and later incorporated into the MZISFDP increasing patient 
acceptance and decreasing the need for adjustments in the zirconia. If changes are made, the 
PMMA prosthesis can either be copied or incorporated in the CAD software and then milled in 
zirconia. Stains can be added both during the actual sintering and post- sintered phases. If 
additional esthetics are required, the MZISFDP can be designed to allow for feldspathic 
veneering porcelain to be added only to non-functional areas such as the facial surface of the 
anterior teeth and prosthetic gingival areas.  
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5.2. Clinical Studies on Monolithic Zirconia Implant Supported Fixed Dental Prosthesis 
(MZISFDP) 
 A review of the current literature shows that there is only one systematic review 
investigating full-arch MZISFDPs.131 Based on the inclusion and exclusion criteria of this study, 
Abdulmajeed et al. identified 9 studies published between 2011 and 2015 on full-arch MZISFPs 
that have been in function for at least one year. Of these, only one was a prospective study while 
three were retrospective studies and 5 were clinical reports. The synthesized data was based on a 
combined 141 full-arch MZISFP and showed a prosthetic cumulative survival rate of 96.8%. 
Five of the nine studies reported no prosthetic complications, while 2 studies reported porcelain 
chipping and 1 study reported multiple complications such as chipping of the opposing denture 
teeth, abutment-related complications, and fractured MZISFDP. The conclusion was that long-
term studies with larger sample sizes are indicated. 
 Out of the 9 studies included in the previously mentioned systematic review only one 
study by Limmer et al.132 was prospective. This study reported on 1 year results of 17 edentulous 
mandibles with full-arch MZISFDPs (ZirkonZahn, Gais, Italy) supported by 4 Astra Tech 
Osseospeed implants (Dentsply Sirona, Salzburg, Austria) built on the abutment level (uni and 
angled abutments, Denstply Sirona, Salzbur, Austria). Besides reporting on biological and 
technical complications, this was the only study on MZISFDPs to evaluate OHRQoL. The 
following technical complications occurred: chipped opposing denture teeth (6/17 subjects), 
fractured abutments (2/17 subjects), loose abutment (1/17 subjects), fractured MZISFDP (1/17 
subjects), and debonded components (1/17 subjects). The only biological complication reported 
after one year was an implant failure (1/17 subjects). The 1 year implant and prosthetic survival 
rates were 99% (66/68 implants) and 88% (15/17 MZISFDPs) respectively.  
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 To evaluate the OHRQoL, Limmer and colleagues used the OHIP-49. They evaluated the 
OHIP-49 at the time of enrollment (prior to any treatment) as a baseline, prior to implant surgery 
(new conventional denture fabricated), and at 6- and 12- months post MZISFDP delivery. A 
study by John et al. reported that a minimal difference of approximately six OHIP-49 units was 
required for a patient to feel “a little better” and a change of about ten units was required for a 
patient to feel “a lot better”.133 Limmer et al. showed that the mean OHIP-49 severity scores 
decreased significantly by an average of 76.8 units from the time of enrollment to 12 months 
post-MZISFDP insertion indicating a profound change in QoL. Furthermore, the biological and 
technical complications encountered did not prevent significant improvement in QoL. Of note, 
the fabrication of a new complete denture showed significant reduction in all 7 OHIP dimensions 
greatly improving QoL. Further significant reductions in total OHIP-49 scores were noted at 6 
months post-MZISFDP delivery and in all dimensions except psychological disability, social 
disability, and handicap. At 12 months, post-MZISFDP, only a small non-significant reduction in 
OHIP-49 scores was noted. 
 A more recent study by Rojas Vizcaya134 reported on 10 edentulous patients restored with 
double arch full-arch MZISFDPs (20 MZISFDPs) after 2-7 years in function. The survival rates 
for both the implant and prostheses were 100%. Complications arose in 2 patients. In one patient, 
the chipping of the pink veneering ceramic for the prosthetic gingiva occurred in the maxillary 
MZISFDP and screw loosening in the mandibular MZISFDP occurred at 36 months in function. 
In the second patient, screw loosening occurred in all 4 screws of the mandibular MZISFDP at 
14 months in function. 
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6. Purpose of the Current Study 
 Currently, long –term clinical studies involving larger sample sizes with full-arch 
MZISFDP is lacking and needed. The purpose of this retrospective study is to report the 1- to 9- 
year clinical results and complications associated with full-arch MZISFDPs in the treatment of 
edentulous patients. Biological and technical complications will be investigated as well as the 
associated OHRQoL. The OHRQoL will be assessed using the OHIP-1484 and the newer Quality 
of Life related to Function, Aesthetics, Socialization, and Thoughts about health-behavioral 
habits’–10 (QoLFAST-10)89. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
     
22  
MATERIALS AND METHODS 
 This study was approved by the University of North Carolina (UNC), Chapel Hill 
Institutional Review Board (IRB # 16-0550) as a retrospective cohort study involving one 
prospective examination. Between June 1, 2008 to September 1, 2015, 63 potential subjects with 
at least one edentulous arch (maxilla and/or mandible) received a full-arch MZISFDP in the 
Graduate Prosthodontics clinic at the UNC, Chapel Hill School of Dentistry. These potential 
subjects are currently still being contacted as the study remains active. 
1. Patient Selection 
Chart numbers were obtained from the electronic patient records at the UNC, Chapel Hill 
School of Dentistry based on the billing code of the prosthesis. Charts were then reviewed by 
one investigator (KL) who then contacted potential study subjects by phone to inform them of 
the purpose of the study including the risks and benefits of participation. The inclusion and 
exclusion criteria for the study were reviewed over the phone. If the potential subject fulfilled 
each inclusion criterion and none of the exclusion criteria and wished to participate, an 
appointment was made for the clinical study visit. Twelve subjects with 14 full-arch MZISFDPs 
were enrolled. 
2. Inclusion and Exclusion Criteria 
2.1. Inclusion Criteria 
Study subjects had to be 18 years and older at the time of enrollment, have good physical 
health (American Society of Anesthesiology Classification I and II (ASA I and II)), be able and 
willing to give informed consent, and have at least one edentulous arch (maxilla and/or mandible) 
restored with full-arch MZISFDP at the Graduate Prosthodontic clinic at the UNC School of 
Dentistry between January 1, 2008 to September 1, 2015. Additionally, pregnant subjects who 
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wished to remain in the study were allowed to do so but were excluded from radiographic 
examination.  
2.2. Exclusion Criteria 
 Potential subjects were excluded from the study if they fulfilled any one of the following 
criteria: history of radiotherapy to the head and neck region; history of intravenous 
bisphosphonate therapy; medical conditions that contraindicate elective dental therapy and 
routine recall appointment; ASA classification III, IV, V and VI; psychological and/or behavioral 
conditions that would make it hard for the patient to cooperate; and known alcohol and/or drug 
abuse.  
2.3. Study Clinical Examination 
 The study consisted of one clinical study visit estimated to last 3 hours. Additional study 
visits were made only if additional data were needed or if any complication arose that required 
treatment. All the study visits were conducted by one investigator (KL) in the Graduate 
Prosthodontic clinic at UNC, Chapel Hill School of Dentistry. The details of the study visit are 
described below.  
2.3.1. Screening and consent 
 In addition to the telephone conversation, a brief screening of the potential subject was 
completed during the clinical visit to confirm eligibility of that subject. The suitable subject was 
then asked if they wished to participate in the study. If they did, the details of the study protocol 
were reviewed. The consent form was reviewed with the patient and they were also given the 
opportunity to read it. After sufficient time was allotted for questions to be asked and all 
questions were adequately answered, the patient provided their consent and they were enrolled in 
the study. All subjects were then asked to complete medical and dental history forms and have a 
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standard digital panoramic radiograph performed (Sirona Orthophos XG 3D, Dentsply Sirona, 
Salzburg, Austria).  
2.3.2. Clinical Examination 
 A standard, thorough comprehensive extraoral (head and neck) and intraoral examination 
of the hard and soft tissues was performed. Attention focused on the dental arch that was restored 
with the MZISFDP. The opposing dentition was examined including the status of the existing 
teeth/restorations (Figure 2). The intraoral examination of the MZISFDP was first conducted 
with the prosthesis in place. The prosthesis was then removed and a detailed examination of 
implants, implant abutments, and peri-implant marginal tissues was completed. The MZISFDP 
and all the screws were examined outside of the mouth. Once the examination was complete, any 
complications that arose were properly addressed, prosthesis cleaned, reseated in the mouth, and 
reattached by torqueing prosthetic/abutment screws, according to the manufacturer’s 
recommendations, followed by placing composite in the screw access holes. All visual 
examinations were conducted with 2.5 times magnification.  
 
Figure 2: Examination of MZISFDP and opposing dentition
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2.3.3. Technical Complications 
 Technical complications associated with the MZISFDP such as the presence of veneering 
porcelain fracture/chipping, framework fracture that resulted in catastrophic failure, missing 
screw access restorative material, and the presence of the prosthesis mobility were examined. 
The prosthetic screw or abutment screw was examined to see if they were still torqued to the 
manufacturer’s recommended torque value (Figure 3). This was accomplished by noting the 
torque value needed to remove the screw. The screw was then removed and visually inspected 
under 2.5 times magnification to see if it was stripped, bent, or fractured. At the implant level, 
when prefabricated abutments were present, they were also tested to see if they were loose or 
their prosthetic platform damaged in any way.  
 
Figure 3: Verifying looseness of implant abutments and prosthetic screws
Torque removal values were verified to see if implant abutments and/or prosthetic screws were 
torqued to the manufacturer’s recommended torque value. 
 
 With the MZISFDP prosthesis removed, the measurements of the length between the 
center of the anterior-most and posterior-most implants on the tissue side of the prosthesis were 
made for the right and left side of the prosthesis using a digital caliper (Figure 4). Thus, the right 
and left side anterior-posterior spreads were recorded. The anterior and posterior cantilevers 
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were also measured on the right and left side of the intaglio surface of the prosthesis (Figure 5). 
The measurement of the cantilever was made from the center of the anterior-most and posterior-
most implant to the facial surface of the most anteriorly restored tooth and the distal surface of 
the most posteriorly restored tooth, respectively. The pontic design was also noted and placed 
into one of the following categories: ridge lap, modified ridge lap, stein, sanitary, and ovate 
pontics (Figure 6). The debonding of titanium bases, used as a secondary titanium interface to 
prevent titanium to zirconia contact, if present, was also investigated. Connector dimensions 
were also recorded at the thinnest sections between implants (Figure 7).  
 
Figure 4: Measurement of anterior-posterior spread
Digital calipers used to measure the center of the implant position of the anterior-most and 
posterior-most implant on the right and left side of the tissue surface of the MZISFDP  
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Figure 5: Measurement of the anterior and posterior cantilever
 
From the intaglio side of the prosthesis digital calipers used to measure the distance from the 
most facial surface of the prosthesis to the center of the anterior-most implant to obtain the 
anterior cantilever measurement. The distance of the center of the posterior-most implant to the 
distal-most surface of the prosthesis to obtain the posterior cantilever measurement. 
Measurements were made on the right and left side of the prosthesis.  
 
Figure 6: Pontic design
 
The contours of the of the tissue surface of the prosthesis were categories based on the pontic 
design 
Image obtained from https://pocketdentistry.com/ceramometal-full-cuverage-restorations/. 
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Figure 7: Connector dimensions
 
The connector (smallest cross sectional area) dimensions between implants were measured in 
the buccal-lingual and apical-coronal dimensions using the digital caliper. 
 
2.3.4. Biological Complications 
 Biological complications associated with the MZISFDP were first assessed. The Calculus 
Retention Index (CRI)135 and the Oral Hygiene Index (OHI)136 were used to evaluate the 
MZISFDP (Table 1). By removing the prosthesis, the tissue surface of the prosthesis was also 
directly examined (Figure 8). Each prosthetically replaced tooth on the MZISFDP was given a 
single score as indicated in Table 1. 
 
Table 1: Calculus Retention Index (CRI) and Oral Hygiene Index (OHI) 
Calculus Retention Index (CRI) 
(Loe 1967)135 
Oral Hygiene Index (OHI) 
(Greene and Vermillon 1964)136 
Score Clinical correlation Score Clinical correlation 
0 No supragingival roughness 0 No debris/stain present 
1 Supragingival roughness detected 1 Soft debris covering < 1/3 tooth or 
extrinsic stain without debris 
2 Subgingival roughness detected 2 Soft debris > 1/3 tooth but < 2/3 
exposed tooth surface 
3 Gross subgingival roughness detected 3 Soft debris > 2/3 of exposed tooth 
surface 
 
  
     
29  
 
Figure 8: Tissue surface of MZISFDP
 
CRI and OHI was applied to the tissue surface of the MZISFDP. 
 
 With the MZISFDP removed the peri-implant marginal tissue was examined (Figure 9). 
Probing depth at 4 points (mesial, buccal, distal, lingual) were recorded (mm) with light pressure 
using a 15 UNC periodontal probe (Hu-Friedy, Chicago, IL). Bleeding on probing was also 
noted at these four points as well as the amount recession (mm). The amount of keratinized 
tissue around each implant was also measured (mm) at the direct facial of all implants as well as 
the direct lingual for mandibular implants. The Modified Sulcular Bleeding Index (mBI) and the 
Modified Plaque Index (mPI) proposed by Mombelli et al was used to evaluate peri-implant 
marginal tissue associated with each implant (Table 2). 137 
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Figure 9: Peri-implant marginal tissues and implant abutments
 
 
Table 2: Modified Plaque Index (mPI) and Modified Bleeding Index (mBI) 
Modified Plaque Index (mPI) 
 (Mombelli et al 1987)137 
Modified Sulcular Bleeding Index (mBI) 
 (Mombelli et al 1987)137 
Score Clinical correlation Score Clinical correlation 
0 No detection of plaque 0 No bleeding when a periodontal 
probe is passed along the mucosal 
margin adjacent to the implant 
1 Plaque only recognized by running a 
probe across the smooth marginal 
surface of the implant 
1 Isolated bleeding spots visible 
2 Plaque can be seen by the naked eye 2 Blood forms a confluent red line on 
mucosal margin 
3 Abundance of soft matter 3 Heavy or profuse bleeding 
 
 The bone-implant interface was then examined by recording the presence of any 
purulence, mobility, and pain on percussion associated with each implant. The digital panoramic 
radiographs obtained during the study visit were compared to the subject’s digital panoramic 
radiograph obtained during the initial insertion of the MZISFDP to evaluate bone loss (Figure 
10). If a digital panoramic radiograph was not present for the day of prosthesis insertion, then the 
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digital panoramic radiograph obtained closest to the day of prosthesis insertion was used. Crestal 
bone loss was evaluated by using a set point, the junction of the platform shift of the implant, and 
the existing level of crestal bone on the mesial and distal aspect of each implant (Figure 11). This 
was done not for accuracy but to see if there was a positive, negative, or non-existent change in 
bone levels around implants. 
 
Figure 10: Marginal Bone Changes
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Figure 11: Measuring radiographic bone changes around implants
     
 The junction of the micro threads and smooth collar meet, where the platform shift is 
accomplished in this Astra Tech Osseospeed TX implant (Dentsply Sirona, Salzburg, Austria) 
 
2.3.5 Patient Centered Outcomes  
  The influence the MZISFDP on quality of life was assessed using the OHIP-1484 and the 
QoLFAST-10. Both questionnaires were administered during the clinical study visit. Subjects 
were asked to consider the influence of the MZISFDP when completing these questionnaires.  
2.4 Review of Subjects’ Records 
 A review of the subject’s patient records located in the electronic patient records at the 
UNC, Chapel Hill School of Dentistry was completed to note any prior technical and biological 
complications. The number of clinical visits needed to address complications in addition to the 
types of implants and abutments placed were recorded. 
2.5 Statistical Analysis 
 Currently, the sample size is too small to evaluate for statistical significance so only 
descriptive statistics were analyzed. The 24th version (2016) of the Statistical Package for the 
Social Sciences (SPSS) software (IBM Corporation, New York, USA) was used for data 
analysis.  
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RESULTS 
 The result from 12 subjects with 14 MZISFDP, 11 in the maxilla and 3 in the mandible, 
are reported on in this paper. The subjects’ and MZISFDPs’ characteristics are listed in table 3 
and 4 respectively. The mean length of MZISFDP use was 41 months. The cumulative survival 
rate of the MZISFDPs was 100% (table 5). The following prosthetic complications were 
encountered and listed, based on at least one occurrence per MZISFDP, in order of most 
common prevalence: loose prosthetic/bridge screw (9/14 MZISFDP), loose prefabricated implant 
abutment (6/12 MZISFDP), missing screw access restorations (5/14 MZISFDP), veneering 
porcelain chipping (2/14 MZISFDP), and debonded MZISFDP titanium abutment or base (2/14 
MZISFDP) (table 6). No zirconia fractures leading to catastrophic failure, fractured abutments, 
and damaged screw threads of any type were noted. 
 A detailed examination of the MZISFDP prosthesis revealed that the majority of 
MZISFDP pontic designs were that of the modified ridge lap (9/14 MZISFDPs) and the minority 
were that of the ovate design (3/14 MZISFDPs), ridge lap (1/14 MZISFDPs) and sanitary pontics 
(1/14 MZISFDPs). The average anterior-posterior spread of implants was 18.04 mm and the 
average anterior and posterior cantilevers were 9.64 mm and 9.06 mm, respectively. The 
anterior-posterior implant spread was greater in the maxilla (17.5 mm) than in the mandible 
(13.5mm). The anterior cantilever was greater in the maxilla (10.4 mm) while the posterior 
cantilever was greater in the mandible (13.25 mm) (Table 7). The average connector dimensions 
were 10.2 x 11.4 mm.  
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Table 3:  Subject Characteristics 
Characteristic Category N Percentage (%) 
All patients  12 100 
    
Sex Male 7 58 
 Female 5 42 
    
Age (years) < 65  3 25 
 65-75 6 50 
 >75 3 25 
   
 
Time MZISFDP use (y)  <3 4 33 
 3–4 6 50 
 >4 2 17 
    
Alcohol consumption No 8 67 
 Yes 4 33 
    
Smoking status Non-smoker 11 92 
 Smoker 1 8 
    
Diabetes mellitus Not diagnosed 9 75 
 Diagnosed 3 25 
    
Bruxism No bruxism 4 33 
 Sleep bruxism 8 67 
    
Oral parafunction No 5 42 
 Yes 7 58 
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Table 4: MZISFDP characteristics 
Characteristic   Category   N   Percentage  (%)  
All  MZISFDP      14   100  
           
Restored  arch   Maxilla   11   79  
   Mandible   3   21  
           
Restorative  platform   Abutment  level   13   93  
   Implant  level   1   7  
           
Pontic  Design	   Modified	  ridge	  lap	   2	   17  
   Ovate        
   Ridge	  lap   8   67  
   Sanitary   4   33  
	   Stein	   	     
           
Opposing  Dentition   Complete  Denture     1   7  
   Full-­arch  MZISFDP   2   14  
   ISOD   1   7  
	   Natural	   dentition/	   tooth	  
supported	  FDPs	   1	  
7  
	   Natural	   dentition,	   tooth	  
supported	  FDP,	  ISFDPs	   7	  
  
50  
 
Table 5: MZISFDP and implant duration and cumulative survival rate 
   Minimum  
duration  
(months)  
Mean  
duration  
(months)  
Maximum  
duration  
(months)  
Standard  
deviation  
(months)  
Cumulative  survival  
rate  (%)  
MZISFDP  
(n=  14)  
20   41   66   14   100  
                 
Implants  
(n=63)  
30   53   72   13   100  
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Table 6: Technical complications 
Technical complication Frequency 
(# of MZISFDP/ total # of 
MZISFDP examined) 
Percentage 
(%) 
Loose bridge screw 9/14 64 
Loose abutment 6/12* 50 
Missing screw access restoration 5/14 36 
Veneering porcelain chipping 2/14 14 
Debonded titanium MZISFDP 
abutment 
2/14 14 
*Only 12 MZISFDP were examined because 1 MZISFDP had no abutments and 1 MZISFDP was 
not checked.  
 
 
Table 7: MZISFDP anterior-posterior spread and cantilevers 
 All MZISFDP 
(mm) 
 
n=14 
Maxillary 
MZISFDP 
(mm) 
 
n=11 
Mandibular 
MZISFDP 
(mm) 
 
n=3 
Average anterior 
posterior spread 
18.0 17.5 13.5 
Average anterior 
cantilever 
9.6 10.4 7.0 
Average posterior 
cantilever 
9.1 7.9 13.3 
 
A total of 63 implants were evaluated with a mean duration of 53 months in function. 57 
of the implants were Astra Tech Osseospeed TX (Dentsply Sirona, Salzburg, Austria) and 6 were 
Nobel Active (Nobel Biocare, Zurich, Switzerland). Thirteen of the fourteen MZISFDP were 
built on prefabricated abutments, 12/14 MZISFDPs were fabricated on the Astra Tech Uni and/or 
Angled abutments (Dentsply Sirona, Salzburg, Austria) and 1/14 MZISFDP on Nobel Active 
Multi-Unit abutments (Nobel Biocare, Zurich, Switzerland). Only one out of the fourteen 
MZISFDPs were built directly to the Astra Tech Osseospeed implants (Dentsply Sirona, 
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Salzburg, Austria). The MZISFDPs were supported by at least 4 implants. The cumulative 
survival rate of the implants was 100%. The mean marginal bone loss for all implants was 0.21 
mm (table 8). No signs of suppuration, pain or mobility associated with the implants were 
encountered.  
Table 8: Peri-implant hard and soft tissues 
 Anterior Implants Posterior Implants All Implants 
 Mean (mm) STD (mm) Mean (mm) STD (mm) Mean (mm) 
Marginal 
Bone Loss 
-0.08 0.82 -0.33 1.00 -0.21 
Peri-implant 
pocket depth 
2.77 0.65 2.53 0.45 2.65 
Keratinized 
tissue 
3.55 1.36 3.04 0.87 3.30 
 
The examination of the peri-implant marginal tissue revealed a mean implant probing 
depth of 2.65mm and a mean keratinized tissue of 3.30mm. Ten out of the fourteen MZISFDPs 
had a mean modified bleeding index (mBI) score of 1, indicating that the majority of implants 
had isolated bleeding spots visible (Table 9). Eight out of the fourteen MZISFDPs had a mean 
individual modified plaque index (mPI) score of 1, indicating that plaque was not recognized by 
the naked eye but only by running a probe across the smooth marginal surface of the implant. 
The other mBI and mPI scores are listed in Table 10. 
 Half (7/14 MZISFDPs) of the MZISFDPs had an average calculus retention index (CRI) 
of 1, indicating the presence of some supragingival calculus, while the other half (7/14 
MZISDPs) of the MZISFDPs had no calculus detected. Ten out of the fourteen MZISFDPs had 
an average oral hygiene index(OHI) score of 1, the others indicating that either less than 1/3 of 
the tooth surface had soft debris and or extrinsic staining. The other CRI and OHI scores are 
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noted in table 11 and 12. 
 
Table 9: Modified bleeding index (mBI) 
Average 
modified 
bleeding 
index 
(individual 
score) 
Clinical examination Frequency 
n= 14 
(# 
MZISFDP) 
Percent  
(%) 
0 No bleeding when a periodontal probe is passed 
along the mucosal margin adjacent to implant  
0 0 
1 Isolated bleeding spots visible 10 71.4 
2 Blood forms a confluent red line on mucosal margin 3 21.4 
3 Heavy or profuse bleeding 1 7.1 
  
 
Table 10: Modified plaque index (mPI) 
Average 
modified 
plaque index 
(individual 
score) 
Clinical examination Frequency 
n= 14 
(# 
MZISFDP) 
Percent  
(%) 
0 No detection of plaque 
 
3 21.4 
1 Plaque only recognized by running a probe across 
the smooth marginal surface of the implant 
 
8 57.1 
2 Plaque can be seen by the naked eye 
 
3 21.4 
3 Abundance of soft matter 
 
0 0 
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Table 11: Average calculus retention index (CRI) – Loe 1967 
Average 
calculus 
retention 
index 
(individual 
score) 
Clinical examination Frequency 
n= 14 
(# 
MZISFDP) 
Percent  
(%) 
0 No supragingival roughness 
 
7 50 
1 Supragingival roughness (Supragingival calculus 
detected) 
 
7 50 
2 Subgingival roughness (subgingival calculus 
detected) 
 
0 0 
3 "Gross" subgingival roughness (Gross subgingival 
calculus) 
 
0 0 
 
 
 
Table 12: Average oral hygiene index (OHI) - Greene and Vermillon 1964 
Average oral 
hygiene index 
(individual 
score) 
Clinical examination Frequency 
n= 14 
(# 
MZISFDP) 
Percent  
(%) 
0 No debris/stain 
 
3 21.4 
1 Soft debris < 1/3 tooth or extrinsic stain w/o debris 
 
10 71.4 
2 Soft debris >1/3 tooth but < 2/3 exposed tooth 
surface 
 
1 7.4 
3 Soft debris > 2/3 of exposed tooth surface 
 
0 0 
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The mean OHIP-14 severity score was 2.6 with a standard deviation of 3.0. The lowest 
and highest severity score was 0 and 9, respectively. Descriptive data for selective patient 
characteristics and mean OHIP-14 severity scores are listed in table 13. The mean QoLFAST – 
10 score was 15.5 with a standard deviation of 5. The lowest and highest severity score was 7 
and 20, respectively. Descriptive data for the different subcategories and dimensions for the 
QoLFAST-10 and OHIP-14 are also listed in table 14. 
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Table 13. Descriptive data for selected patient characteristics and mean (standard deviation) 
OHIP-14 severity scores  
Characteristic Category N Mean 
Std. 
Dev. 
All patients … 12 2.6 3.0 
     
Sex Male 7 3.7 3.5 
 Female 5 1.0 1.4 
     
Age (y) <65 3 4.7 4.5 
 65–75 6 2.2 2.8 
 >75 3 1.3 1.2 
     
Time MZISFDP use 
(y)  <3 4 1.3 1.5 
 3–4 6 2.5 3.0 
 >4 2 5.5 4.9 
     
Alcohol consumption No 8 1.6 1.9 
 Yes 4 4.5 4.2 
     
Smoking status Non-smoker 11 2.4 3.1 
 Smoker 1 5.0 0.0 
     
Diabetes mellitus Not diagnosed 9 1.8 2.9 
 Diagnosed 3 5.0 2.0 
     
     
Bruxism No bruxism 4 1.8 1.3 
 Sleep bruxism 8 3.0 3.6 
     
Oral parafunction No 5 1.0 1.4 
 Yes 7 3.7 3.5 
     
Bone loss (a) No 1 2.0 0.0 
 Yes 10 2.6 3.3 
     
N extra visits: 
technical 
None 
2 3.5 2.1 
 ≥1 10 2.4 3.2 
     
N extra visits: 
complication/s 
None 
5 2.0 2.1 
 ≥1 7 3.0 3.7 
… Not applicable 
(a)  Categories sum to 11 as information not reported for one patient	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Table 14: Descriptive data for different categories/dimensions of QoLFAST-10 and OHIP-
14 
 
Subscale and total scores 
Monolithic Zirconia 
Implant Supported 
Fixed Dental 
Prosthesis Subjects 
(MZISFDP, n = 12) 
Mean (SD) 
QoLFAST – 10   
Social 6.5 (2.2) 
Aesthetic 3.3 (1.2) 
Functional 2.4 (2.0) 
Thoughts about health-behavioral 
habits 
3.1 (1.1) 
QoLFAST -10 total Score 15.5 (5.0) 
  
OHIP-14  
Functional limitation 1.1 (1.6) 
Physical pain 0.7 (1.1) 
Psychological discomfort 0.5 (1.2) 
Physical disability 0.2 (0.4) 
Psychological disability 0.3 (0.6) 
Social disability 0 (0) 
Handicap 0.1 (0.2) 
OHIP-14 total score 2.6 (3.0) 
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DISCUSSION 
 The cumulative survival rate for the edentulous subjects treated with full-arch MZISFDP 
were 100% for both the prosthesis and the implants after a mean duration of 41 months. 
Although the current sample size is small, the survival rates shown in this study are similar to 
that of other published full-arch ISFDPs survival rates. A systematic review by Lambert FE et 
al.138, examining full-arch ISFDPs restoring the edentulous maxilla showed an overall implant 
survival rate of 92.3 % (3 years), 90.7% (5 years) and 90.3 (10 years). When only roughened 
implant surfaces were included the implant survival rate increased to 98% after 3 -10 years. The 
study examined both full-arch metal-ceramic ISFDPs and MAISFDPs and revealed an overall 
prosthodontic survival rate of 95.8% (3 years), 94.6% (5 years), and 92.1% (≥10 years).  The 
survival rates for metal-ceramic ISFDPs were 100% (3-5years) and 96.4% (≥10 years) and for 
MAISFDPs they were 84% (3 years), 93.39% (5 years) and 91.7 % (≥10 years). The difference 
between the two types of implant supported prosthesis were not statistically significant.  
In another systematic review focusing on full-arch ISFDPs in the edentulous mandible, 
Papaspyridakos P et al.139 showed a cumulative implant survival rate of 98.42% (5 years) and 
96.86% (10 years) for roughened implants. The cumulative prosthetic survival rate for full-arch 
ISFDPs were 98.61% (5 years) and 97.25% (10 years). The survival rates for metal-ceramic 
ISFDPS were 100% (5 and 10 years) and for MAISFDPs they were 98.56% (5 years) and 
97.13% (10 years). There was no statistical significance between the two different materials used 
to fabricate the ISFDP. 11 failures were noted with the MAISFDP and none in the metal-ceramic 
ISFDPs but far more MAISFDPs (n=469) were examined when compared to metal-ceramic 
ISFPS (n=32). 
 Although the study shows high survival rates for both the prosthesis and implants, the 
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data must be interpreted carefully. One of the weaknesses of this study, besides being a 
retrospective study, is that it does not properly account for MZISFDPs that have failed. Full-arch 
MZISFDPs that were no longer in function were not examined in this study. An example of this 
was a subject who was fully edentulous and treated with dual-arch MZISFDPs. A review of the 
subject’s chart showed repeated problems with the mandibular MZISFDP and subsequent 
treatment in the Graduate Prosthodontics clinic at UNC, Chapel Hill, School of Dentistry. The 
original mandibular full-arch MZISFDP had to be replaced after 34 months in function due to a 
fractured implant (Astra Osseospeed TX, Dentsply Sirona, Salzburg, Austria). Additionally, 3 
out of the 4 prefabricated implant abutments (Uni Abutment, Denstsply Sirona, Salzburg, 
Austria) had also fractured. The fractured implant had occurred after the maxillary complete 
denture was replaced by full-arch MZISFDP 5 months prior. The mandibular full-arch 
MZISFDP was refabricated after the replacement for the failed implant had integrated. Over the 
next year, the subject continued to have prosthetic complications that included fracturing of 
prefabricated implant abutments (Uni Abutment, Denstsply Sirona, Salzbur, Austria), 
prosthetic/bridge screw fractures, and secondary titanium abutment debonding in the MZISFDP. 
The subject also exhibited some chipping in the veneering ceramic of her anterior teeth. Further 
investigation revealed that the previous MZISFDPs were fabricated based on improper centric 
relation records. In addition to improper centric relation records to which the MZISFDP was 
fabricated, this subject displayed similar risk factors (history or bruxism and opposing implant 
prosthesis) that Kinsel and Lin76 identified in ceramometal ISFDPs that lead to increased ceramic 
fractures/chipping. The weak point in this MZISFDP, however, wasn’t the porcelain but may be 
the prefabricated implant abutments and implants. Other factors such as anterior-posterior spread 
of implants, cantilever lengths, and thickness of the material may have also played a role in the 
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complications but were not evaluated or noted in the subject’s records.   
 This study measured the anterior-posterior spread of the MZISFDP as well as both the 
posterior cantilever, which is most commonly reported, and the anterior cantilever. The average 
anterior-posterior spread of the implants for the MZISFDP was 18 mm and the average posterior 
and anterior cantilever were 9.01mm and 9.6mm. The cantilever length to anterior posterior 
spread ratio (CL-AP) from our study did not violate the previously published CL-AP ratio of 
1.5140 or 2.0141. In a current publication, Rojas Vizcaya134 reports the 2-7 year results on 10 fully 
edentulous patients restored with double full-arch MZISFDPs (20 MZISFDPs). The survival rate 
for both the implant and prosthesis was 100%. The mean maxillary and mandibular posterior 
cantilever was 6.6 mm and 12.22 mm, respectively. These published values didn’t differ too 
much from our reported mean maxillary and mandibular posterior cantilevers of 7.9mm and 
13.3mm. In 2014, Limmer et al.132 reported a fracture in the cantilevered segment of a 
mandibular MZISFDP opposing a complete denture after 6 months in service. The fractured 
segment had a posterior cantilever of 17mm which was far greater than that published by Rojas 
Vizcaya134 (12.22mm) and our results (13.3mm). Excessive cantilever can negatively influence 
proper biomechanics in implant-supported prosthesis and can result in overloading142 which may 
result in the fracture of the prosthesis and/or abutment screws143 144, implant fracture145, loss of 
osseointegration146, and loosening of the prosthesis retaining screws147.  
 The most common technical complications (Figure 11) was the presence of loose bridge 
screws in the MZISFDP (64% MZISFDPs) which was higher than what Bozini82 reported after 5 
(5.3%), 10 (10.3%), and 15 (15%) years respectively. Though our values were higher, it is hard 
to ascertain if the bridge screws had in fact really become loose or if they were inadequately 
tightened to the manufacturer’s recommended torque value. Similarly, the loosening of 
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prefabricated implant abutments, when present, occurred in 50% of the MZISFDPs. Krennmair S 
et al.148 reported that 16% of the implant abutments in their MAISFDP study had become loose 
after 3 years of function. An interesting finding was that the presence of loose prosthetic screws 
or abutments were not detectable without detaching the prosthesis. Manipulation, alone, of the 
prosthesis failed to identify these loosened components. They also reported that the implant 
screw hole access restorations were found missing in 16 % of their MAISFDPs. Our study 
showed a higher occurrence of missing screw hole access restorations (36%) associated with our 
full-arch MZISFDPs.  
 
Figure 12: Technical complications 
a) 
Porcelain chipping and staining, b) Porcelain chipping, c) Damaged prosthetic screw, d) 
Missing screw access hole restoration, e) Loose implant abutment and MZISFDP titanium base, 
f) Loose implant abutment 
  
Papaspyridakos P et al78  showed that veneering material chipping or fracture was the 
most reported prosthetic complication associated with MAISFDPs with a cumulative 5 and 10 
year estimated complication rate of 33% and 66% respectively. Our study showed that chipping 
of the veneering porcelain occurred in 14% of the MZISFDPs after an average of 41 months. 
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Papaspyridakos P et al. also reported additional complications associated with the resin teeth 
used in MAISFDPs such as the total replacement of teeth, which had an estimated 5- and 10-year 
estimated complication rate of 16.2% and 32.4% respectively, and the wear of acrylic denture 
teeth, which had an estimated 5- and 10-year estimated complication rate of 10% and 20% 
respectively. Besides the fracturing of the veneering porcelain, no signs of material wear or the 
need for replacement were observed in the MZISFDPs. 
 Debonding of the titanium abutments/base found within the MZISFDP occurred in 14% 
of the prosthesis and was a unique complication not encountered in any of the MAISFDPs. A 
titanium interface is used in zirconia restorations to allow for a titanium (implant) to titanium 
(prosthesis) interface, instead of a titanium (implant) to zirconia (prosthesis) interface, to 
decrease zirconia fractures. Higher strength is achieved when a secondary metallic component is 
used.149 However, the weak point in these zirconia prostheses connected to titanium bases is their 
connection. They are often connected by a resin-based luting agent150 which remains a weak 
point crucial for long-term clinical success151.  
Studies 152 153 examining the luting of secondary titanium bases to zirconia have shown 
that the primary mode of failure were adhesive failures indicating the weak bond to zirconia. 
Gehrke R et al.152 investigated the influence of mechanical surface treatments to both the 
titanium base and zirconia prior to luting with a resin-based cement. Both surfaces were treated 
with 50 microns of aluminum-oxide particles at 2 bars pressure (0.25 MPa) for 20 seconds at a 
distance of 10mm. Luting was completed with three different resin-based cements: Panavia 21 
(Kuraray Co, Kurashiki, Japan), Multilink Implant cement (Ivoclar Vivadent, Schaan, 
Liechtenstein), and Smart-Cem 2 (Desntplsy DeTrey, Konstanz, Germany) showing an increase 
in mean retention values leading to sufficient stable retention between the zirconia and titanium 
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base. Although the different resin-based cements had differing mean retentive values (Panavia 
21: 924.93N, Multilink Implant: 878.05N, Smart Cem 2: 650.77N) none showed statistically 
significant difference. Von Maltzahn et al.153 later investigated the additional effects of chemical 
surface treatment in addition to mechanical treatment when luting zirconia to titanium baes with 
resin-based cements. They showed that chemical surface treatment to both mechanically treated 
zirconia and titanium bases in when cemented with resin-based cements showed statistically 
significant increases in retentive forces. Clearfil ceramic primer (Kuraray, Europe), a silane-
coupling agent, when compared to Alloy primer (Kuraray, Europe) and Rocatec, showed better 
results. Despite the increased retentive strength values achieved with both mechanical and 
chemical surface treatments the primary mode of failure in the bond between the titanium bases 
and zirconia were adhesive failures. In addition, the mechanical treatment of zirconia can still 
lead to detrimental micro cracks that convert the more stable tetragonal form of zirconia to its 
monoclinic form. Further studies are needed to investigate the proper protocol to mechanically 
treat the surface of zirconia or a sufficient chemical form of surface treatment.  
The two MZISFDPs that experienced debonding (Figure 12) of the titanium abutments 
were both mandibular MZISFPs initially cemented with a resin modified glass ionomer cement 
(Fuji-Cem, GC America). One of the two MZISFPs had experienced previous debonding. In all 
cases, after proper seating was verified intraorally, excess cement was removed from the 
titanium bases by using 50 microns’ aluminum oxide particles at 2 bars pressure (0.25 MPa) at a 
distance of 10mm for 20 seconds. Due to adhesive failure, barely any cement was left on the 
zirconia. Ivoclean (Ivoclar, Schaan, Leichtenstein) was used according to the manufacturer’s 
recommendations to decontaminate the zirconia from any phosphate groups154 found in saliva, 
which decreases potential bond strength, followed by steam cleaning. Monobond Plus was 
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applied to both the zirconia and titanium bases accordingly and either Multilink or Variolink DC 
was used to lute the two components extraorally according to the manufacturer’s 
recommendations. Despite employing mechanical and chemical surface treatments of the 
components with a resin-based cement debonding occurred again in one of these MZISFDP 
suggesting that other factors may be present that contribute to adhesive failure. The posterior 
cantilever lengths of 14 and 10.75 mm were within the CL-AP ratio guidelines of 1.5 published 
by English140 . The opposing dentition of both subjects with debonded titanium abutments were 
implant supported (ISOD and full-arch MZISFDP). 
 
Figure 13: Debonded titanium abutments/bases in MZISFDPs 
 
 
In addition to improvements concerning titanium to zirconia bonding protocols other 
design changes can be made to help increase mechanical retention. The titanium bases that had 
become debonded exhibited the minimal requirements for adequate retention and resistance 
form, such as taper155 and axial wall heights156, required in traditional crown and bridge tooth 
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preparation (Figure 13). Since these titanium abutments/bases support full arch prostheses, often 
with cantilevers, alterations to their wall heights and taper may be another way to help increase 
mechanical retention. Another option is to use a splinted, bar-like substructure that allows for 
greater surface area for the luting of the zirconia suprastsructure. One MZISFDP was observed in 
our study exhibits this design (Figure 14). One issue encountered with this prosthesis involved 
the improper surface finishing between the junction of the titanium substructure and the zirconia 
suprastructure. Calculus was found on the rough surfaces between these two platforms. Special 
attention must be made to ensure a seamless, smooth junction between the two components to 
help ensure proper oral hygiene that decreases plaque and calculus accumulation. One MZISFDP 
demonstrated a direct zirconia to implant abutment connection (Figure 15). Although this design 
would eliminate the occurrence of debonded titanium abutments and have the potential of a more 
favorable soft tissue response, zirconia chipping, as seen in this prosthesis, can occur at a higher 
rate. Further studies are also needed to evaluate the proper design for either titanium solitary 
abutments or splinted substructures.  
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Figure 14: Design of debonded titanium abutments 
 
 
 
 
Figure 15: Bar substructure MZISFDP 
 
a) Immediate removal of MZISFDP shows large amounts of plaque and calculus, b) improper 
finishing of bar substructure and zirconia suprastructure 
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Figure 16: Direct zirconia to implant abutment MZISFDP 
 
a)4 anterior implant abutments directly contacted the zirconia and showed a more favorable tissue 
response than when titanium bases were uses (b) but fracture of the zirconia when directly 
contacting the abutments is a concern. 
 
The average peri-implant pocket depth in our MZISFDP study was 2.65 mm for all 
implants and 2.77 mm for anterior implants and 2.53 mm for posterior implants. Krenamir S et 
al. showed similar peri-implant pocket depths associated with MAISFDPs after three years for 
their anterior (2.4-2.5mm) and posterior implants (2.7-2.8mm). An average of 3.3 mm of 
keratinized tissue was found around all implants. Although our use of a non-standardized digital 
panoramic radiograph to evaluate bone levels around implants was not the ideal method, our 
results show a mean marginal bone loss of 0.21mm. These values imply a favorable response of 
the peri-implant hard and soft tissue associated with the MZISFDP.  
A review of the different periodontal indices (Table 13) shows that the MZISFDPs had an 
average modified bleeding index (mBI) of 1 (71.4%) indicating mild inflammation was present 
in the surrounding peri-implant tissue. The average modified plaque index (mPI) score was either 
1 (57%) or 0 (21%) indicating that most MZISFDP had plaque that was only detectable by 
running an instrument through the smooth marginal surface of the implant (mPI score 1) or not 
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detectable (mPI score 0). The average calculus retention index (CRI) revealed that 50% of the 
MZISFDP had no detectable calculus and the other 50% had suprgingival calculus detected. A 
majority of the MZISFP (71%) had an average oral hygiene index (OHI) of 1 indicating that 
either some soft debris was found to cover less than a 1/3 of the tooth or extrinsic stains were 
present.  
Table 15: Average Individual Indices 
Index Average 
Score 
Clinical Correlation Frequency 
(#/MZISFDP) 
Percent 
(%) 
Prosthesis Level 
(MZISFDP) 
    
Oral Hygiene Index 
(OHI) 
1 Soft debris < 1/3 of tooth or 
extrinsic stain w/o debris 
present 
10/14 71 
Calculus Retention 
Index (CRI) 
0 No supragingival roughness 7/14 50 
 1 Supragingival roughness 
(supragingival calculus 
detected) 
7/14 50 
     
Implant/Abutment 
Level  
    
Modified Bleeding 
Index (mBI) 
 
1 Isolated bleeding spots 10/14 71.4% 
Modified Plaque Index 
(mPI) 
1 Plaque only recognized by 
running a probe across the 
smooth marginal surface of 
the implant 
 
8/14 57.1 
 
 One difference in the design of this study is that it involved the removal of the MZISFDP 
allowing direct examination of the implants and the peri-implant marginal tissue. Without the 
removal of the prosthesis certain technical complications, such as loose prosthetic screws and 
abutments, and biological complications, such as inflammation of the peri-implant marginal 
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tissue, could easily be missed during a clinical examination. With a screw-retained MZISFDP 
removal of the prosthesis is easily achievable but the frequency to which this occurs often varies 
from one practitioner to the other. In 2016, Bidra AS et al.157 published clinical practice 
guidelines for recall and maintenance of patients with full-arch ISFDPs. Proper recall 
examinations should occur at least every 6 months and consists of a thorough examination, 
prophylaxis, and oral hygiene instructions for the lifetime of the patient. In addition to that, 
professional intervention is indicated to ensure that the ISFDP maintains optimal mechanical 
function and allows for proper biological health around the peri-implant hard and soft tissue. If 
adjustment or replacement of the prosthesis is indicated and/or the patient demonstrates the 
inability to perform adequate oral hygiene, then the ISFDP should be removed. Bidra et al. also 
suggested the replacement of all prosthetic screws when reattaching the ISFDP.  An occlusal 
device, such as an occlusal guard, is also recommended when indicated. The occlusal device 
should be treated as a prosthesis that needs to be maintained both professionally, to allow 
optimal function, and by the patient, so it is used properly. Although these recommendations 
may prove to be highly beneficial in improving patient care and clinical outcomes they are 
largely based on expert opinions and extrapolated data from published studies. Future studies 
based on higher levels of evidence, such as randomized controlled studies, are still indicated.    
The average OHIP-14 score for our MZISFP subjects was 2.6 with a standard deviation 
(STD) of 3.1. The low severity score shows that the MZISFP had very little adverse impact on 
quality of life. Preciado et al.158 showed average OHIP-14 scores of 2.8 (4.8 STD) for 
MAISFDPs (2.8, 4.8 STD), 1.6 (3.0 STD) for dentate tooth and implant supported FDPs, and 1.7 
(2.7 STD) for metal-ceramic ISFDP. Although we cannot directly compare our results with other 
studies, our results show similar mean OHIP-14 scores to the metal-acrylic ISFDP. Similarly, our 
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average QoLFAST-10 scores were 15.5 (5.04 STD) which is higher than the mean scores 
Castillo-Oyagüe R et al. showed for MAISFDPs (10.7, 7.3 STD), ISOD (8.5, 6.0 STD), and 
muco-supported complete dentures (10.5, 4.0 STD). The high OHIP-14 and QoLFAST-10 scores 
show that subjects were very satisfied with the MZISFDP and they experienced similar or better 
OHRQoL as patients with full-arch MAISFDPs to treat edentulism.  
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CONCLUSION 
 Under the current limitations of the study, our initial findings show that full-arch 
MZISFDP are a viable treatment option for the edentulous arch. The implant and prosthesis 
survival rate after an average of 41 months was 100%. Compared to the more commonly used 
full-arch metal acrylic ISFDPs technical complications such as veneering material fracture and 
wear associated with acrylic denture teeth are greatly decreased. However, MZISFDPs have their 
own set of unique technical complications such as the debonding of titanium inserts. Patient 
related outcomes evaluating OHRQoL (OHIP-14 and QoLFAST-10) show similar or better 
patient related outcomes as full-arch MAISFDPs. 
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APPENDIX A 
 
Oral Health Impact Profile – 14 (OHIP-14) 
 
The questions below ask about troubles that people may have in daily life because of 
dental problems.  
HOW OFEN during the last year … Please tick ONE box that best describes your 
experience. 
1.   … have you had trouble 
pronouncing any words because of 
problems with your teeth, mouth or 
dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
 
2.   … have you felt that your sense of 
taste has worsened because of 
problems with your teeth, mouth or 
dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
3.   … have you had painful aching in 
your mouth? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
4.   … have you found it uncomfortable 
to eat any foods because of problems 
with your teeth, mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
5.   … have you been self-conscious 
because of problems with your teeth, 
mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
6.   … have you felt tense because of 
problems with your teeth, mouth or 
dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
7.   … has your diet been unsatisfactory 
because of problems with your teeth, 
mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
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8.   … have you had to interrupt meals 
because of problems with your teeth, 
mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
9.   … have you found it difficult to 
relax because of problems with your 
teeth, mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
10.  … have you been a bit embarrassed 
because of problems with your teeth, 
mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
11.  … have you been a bit irritable with 
other people because of problems 
with your teeth, mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
12.  … have you had difficulty doing 
your usual jobs because of problems 
with your teeth, mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
13.  … have you felt that life in general 
was less satisfying because of 
problems with your teeth, mouth or 
dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
14.  … have you been totally unable to 
function because of problems with 
your teeth, mouth or dentures? 
Very  
Often 
Fairly  
Often Occasionally 
Hardly  
Ever Never 
1 2 3 4 5 
 
Adapted from: Slade, G.D. (1997) Derivation and validation of a short-form oral health impact 
profile. Community Dentistry Oral Epidemiology 25: 284-290. 
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APPENDIX B 
Quality of Life related to Function, Aesthetics, Socialization, and Thoughts about health-
behavioral habits’ (QoLFAST-10) 
*Please indicate your level of agreement with the following statements and give the appropriate score in each case: 
Quality of Life related to Function, Aesthetics, 
Socialization, and Trends of health-behavioral 
habits (QoLFAST 10) 
Strongly 
Disagree 
(-2) 
Disagree 
(-1) 
Indecisive, 
indifferent, 
or neutral (0) 
Agree 
(+1) 
Strongly 
Agree (+2) 
D1. Social      
1) You feel comfortable in social situations 
with your implant prosthesis 
     
2) You can eat well with your implant 
prosthesis, which has a positive social 
repercussion  
     
3) If you suffer oral pain due to your implant 
prosthesis, such pain has no social impact 
     
4) Your implant prosthesis helps you 
developing your daily activities 
     
      
D2. Aesthetics      
5) You are satisfied with the size, shape, and 
color of your prosthetic teeth  
     
6) You smile confidently with your implant 
prosthesis 
     
      
D3. Functional       
7) You clean your mouth and implant 
prosthesis without difficulties 
     
8) You can speak well with your implant 
prosthesis 
     
      
D4. Thoughts about health - behavioral 
habits’  
     
9) You consider that your daily habits of oral 
hygiene are decisive for the maintenance of 
your implant prosthesis 
     
10) You consider that oral revisions are 
essential to improve your quality of life and 
the durability of your implant prosthesis 
     
      
Total score of the QoLFAST-10 scale      
 
Questionnaire taken from: Castillo-Oyagüe R, Suárez-García MJ, Perea C, Río JD, Lynch CD, Gonzalo E, Torres-Lagares D, Preciado A. Validation of a new, specific, 
complete, and short OHRQoL scale (QoLFAST-10) for wearers of implant overdentures and fixed-detachable hybrid prostheses. J Dent. 2016 Jun;49:22-32.  
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